Nothing Special   »   [go: up one dir, main page]

DE60130465D1 - Mutierte muskelspezifische enhancer - Google Patents

Mutierte muskelspezifische enhancer

Info

Publication number
DE60130465D1
DE60130465D1 DE60130465T DE60130465T DE60130465D1 DE 60130465 D1 DE60130465 D1 DE 60130465D1 DE 60130465 T DE60130465 T DE 60130465T DE 60130465 T DE60130465 T DE 60130465T DE 60130465 D1 DE60130465 D1 DE 60130465D1
Authority
DE
Germany
Prior art keywords
muted
muscle
specific enhancer
muscle specific
expression systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130465T
Other languages
English (en)
Other versions
DE60130465T2 (de
Inventor
James S Chamberlain
Stephen D Hauschka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
University of Michigan
Original Assignee
University of Washington
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, University of Michigan filed Critical University of Washington
Application granted granted Critical
Publication of DE60130465D1 publication Critical patent/DE60130465D1/de
Publication of DE60130465T2 publication Critical patent/DE60130465T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1223Phosphotransferases with a nitrogenous group as acceptor (2.7.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/42Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60130465T 2000-07-14 2001-07-13 Mutierte muskelspezifische enhancer Expired - Lifetime DE60130465T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21843600P 2000-07-14 2000-07-14
US218436P 2000-07-14
PCT/US2001/022092 WO2002006495A2 (en) 2000-07-14 2001-07-13 Mutant muscle-specific enhancers

Publications (2)

Publication Number Publication Date
DE60130465D1 true DE60130465D1 (de) 2007-10-25
DE60130465T2 DE60130465T2 (de) 2008-06-12

Family

ID=22815112

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130465T Expired - Lifetime DE60130465T2 (de) 2000-07-14 2001-07-13 Mutierte muskelspezifische enhancer

Country Status (7)

Country Link
US (1) US20110097761A1 (de)
EP (1) EP1303617B1 (de)
AT (1) ATE373095T1 (de)
AU (1) AU2294102A (de)
DE (1) DE60130465T2 (de)
HK (1) HK1055444A1 (de)
WO (1) WO2002006495A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011051450A1 (en) * 2009-10-29 2011-05-05 Vib Vzw Cardiac-specific nucleic acid regulatory elements and methods and use thereof
CN104031919B (zh) * 2014-03-24 2017-04-19 内蒙古大学 一种能够在哺乳动物肌肉组织中特异启动基因表达的启动子序列及其应用
MA45477A (fr) 2016-04-15 2019-02-20 Res Inst Nationwide Childrens Hospital Administration à vecteurs de virus adéno-associé de microarn-29 et micro-dystrophine pour traiter la dystrophie musculaire
CA2971303A1 (en) 2016-06-21 2017-12-21 Bamboo Therapeutics, Inc. Optimized mini-dystrophin genes and expression cassettes and their use
EP3697915A4 (de) 2017-10-18 2021-12-08 Research Institute at Nationwide Children's Hospital Adeno-assoziierte virusvektorverabreichung von muskelspezifischem mikrodystrophin zur behandlung von muskeldystrophie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994132A (en) * 1996-10-23 1999-11-30 University Of Michigan Adenovirus vectors

Also Published As

Publication number Publication date
EP1303617A2 (de) 2003-04-23
DE60130465T2 (de) 2008-06-12
ATE373095T1 (de) 2007-09-15
AU2294102A (en) 2002-01-30
US20110097761A1 (en) 2011-04-28
WO2002006495A2 (en) 2002-01-24
EP1303617B1 (de) 2007-09-12
WO2002006495A3 (en) 2002-07-04
HK1055444A1 (en) 2004-01-09

Similar Documents

Publication Publication Date Title
WO2003080807A3 (en) Compositions and methods for suppressing eukaryotic gene expression
NZ504185A (en) Expression of endogenous genes by non-homologous recombination of a vector construct with cellular DNA
DK0973928T3 (da) DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
ATE352638T1 (de) REVERSE ßTWO-HYBRIDß-SYSTEME
NZ538852A (en) Selection and isolation of living cells using mRNA-binding probes
WO2000073764A3 (en) Composition and methods for the therapeutic use of an atonal-associated sequence
WO2004010925A3 (en) Mammalian genes involved in viral infection and tumor suppression
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
CY1110535T1 (el) Μεταλλαξεις του γονιδιου της παρκινης, συνθεσεις, μεθοδοι και χρησεις
DE60130465D1 (de) Mutierte muskelspezifische enhancer
DE69739346D1 (de) Gereinigtes sr-p70 protein
EP0763205A4 (de) Nukleinsäuresequenzen die lungenzellenspezifishe genexpression kontrollieren
WO2004085681A3 (en) Global linear non-biased nucleic acid amplification
DE60131973D1 (de) Regulation der upa gen-expression durch methylierte nukleotide
ATE509947T1 (de) Nukleinsäure involviert im responder phenotyp und deren verwendung
Raae et al. Preparation and separation of d (pT) 10. n oligonucleotides
HUP0400915A2 (hu) Növényi reprodukciós proteinek
TW200519200A (en) Method of searching for functional nucleotide molecule
AU8013798A (en) Yeast cells comprising at least two copies of a desired gene integrated into thechromosomal genome at more than one non-ribosomal rna encoding domain, particul arly with kluyveromyces
DE60034953D1 (de) Genklonierung
NZ501962A (en) Vertebrate telomerase genes and proteins and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition